Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivo Bio Tech Ltd has submitted newspaper clippings published on February 9, 2026, in Financial Express (English) and Nava Telangana (Telugu) to BSE. The publication notifies shareholders about a special window to re-lodge transfer requests for physical shares, in line with SEBI Circular dated January 30, 2026. The disclosure is filed under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The special window allows holders of physical share certificates to re-submit pending transfer requests and convert their holdings into dematerialised (demat) form. This is a routine regulatory compliance filing with no change to the company's financials or operations.
No direct impact on shareholders or stock price. Shareholders holding physical share certificates may use this special window to re-lodge pending transfer requests and convert their shares to demat form.